Clinical observation on the application of wireless analgesia system in treatment of refractory cancer pain
- VernacularTitle:应用无线镇痛系统治疗难治性癌痛的临床观察
- Author:
Shuang FU
1
;
Pisheng QU
;
Xiaohong YUAN
;
Ye GUO
;
Lixia HUANG
Author Information
1. 浙江省肿瘤医院麻醉科
- Keywords:
Wireless analgesia system;
Morphine;
Refractory cancer pain
- From:
China Modern Doctor
2015;(2):104-106
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of wireless analgesia system percutaneous morphine pumping in patients with refractory cancer pain. Methods A total of 19 patients with refractory cancer pain underwent continu-ous percutaneous morphine via wireless patient-controlled analgesia pump to replace the oral morphinefrom Feb 2013 to Oct 2013 were included. Recorded the pain relief time,degree and remission rate,dosing adjustment completion time and adverse reactions. And compare visual analogue scale(VAS﹚before and after 3 days and morphine consumption 24 hours of total. Results The average time of beginning of pain relief was 35 min. The VAS before and after treatment were 7(1﹚and 1(1﹚respectively(P﹤0.01﹚, morphine consumptions were (92.6±21.3﹚mg and (31.0±9.34﹚mg. The de-gree of pain relief was 94.7%(18/19﹚. The average completion time of morphine titration was 38.4 hours. The main adverse reaction of constipation,nausea and vomiting,urinary retention and psychiatric symptoms were recorded. Conclusion Wireless analgesia system continuous percutaneous morphine pumping can effectively control the in-tractable cancer pain, is safe, efficient, convenient, and reduce morphine refractory cancer pain patientsdosage.
